articles about Foot and mouth disease in Press releases

Inovio Pharmaceuticals enters collaboration with U.S. Dept. of Homeland Security to assess foot & mouth disease synthetic vaccines' potential to help ensure Nation's food supply safety

29-Sep-2011
Inovio Pharmaceuticals, Inc., a leader in the development of synthetic immunogens against cancers and infectious diseases, announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United States Department of Homeland Security (DHS) Science and Technology Directorate Plum Island Animal Disease Center. This collaboration will evaluate the efficacy of Inovio's SynCon® vaccines for foot & mouth disease (FMD) in important animal models including cattle, sheep, and pigs.